AUPH Q2 2020 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29,000+0.0% YoY

Gross Profit

$29,000100.0% margin

Operating Income

-$27M-92631.0% margin

Net Income

-$27M-91531.0% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

-3.3%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$295M

Total Liabilities

$56M

Stockholders' Equity

$239M

Cash & Equivalents

$232M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29,000	$29,000	+0.0%
Gross Profit	$29,000	-$11M	+100.3%
Operating Income	-$27M	-$16M	-63.3%
Net Income	-$27M	-$16M	-66.9%